COO vs IMA · P/E 36, rev $4.09B vs rev $9.2M
The Cooper Companies, Inc (COO) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. Revenue was up 5.1% from 2024-10-31 to 2025-10-31. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
COO currently screens at market cap $14.92B and trailing P/E 36.1. IMA currently screens at market cap $64.7M.
Not investment advice. Open the COO and IMA stock pages for the full models.
Not investment advice.